What is Molnupiravir?

sfg-2026
NEWS
  1. 11 May | Right Approach to Study Economy For Beginners Click Here
  2. 05 May | Caution!! You may enter into No productivity Zone Click Here
  3. 07 May | How Toppers identify the Implicit Demand of the Question Click Here to watch Ujjawal Priyank IAS AIR 10 Strategy →

Source : Click here

News: A new drug called Molnupiravir has been shown to stop the transmission of SARS-CoV-2 (COVID-19) in 24 hours.

Facts:

  • Molnupiravir: It is an experimental antiviral drug which is orally active (can be taken orally) and was developed for the treatment of influenza.
  • Developed by: The drug is being developed by the biotechnology firm Ridgeback Biotherapeutics in collaboration with pharmaceutical firm Merck.
  • Significance: This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission and it can be a game-changer
Print Friendly and PDF
Blog
Academy
Community